Table 1 Comparison of the baseline characteristics between OH and LH groups
Variables | OH group (n=78) | LH group (n=29) | P value |
|---|---|---|---|
Age, year | 66.3±4.5 | 66.0±4.1 | 0.752 |
Sex, n (%) | Â | Â | 0.123 |
 Male | 49 (62.8%) | 13 (44.8%) |  |
 Female | 29 (37.2%) | 16 (55.2%) |  |
BMI, kg/m2 | 23.8±3.7 | 24.8 ±3.8 | 0.200 |
Cirrhosis of the liver | 11 (14.1%) | 5 (17.2%) | 0.921 |
Portal hypertension | 2 (2.6%) | 0 (0.0%) | 1.000 |
Ascites | 2 (2.6%) | 0 (0.0%) | 1.000 |
COPD | 6 (7.7%) | 1 (3.4%) | 0.727 |
Diabetes | 10 (12.8) | 7 (24.1) | 0.260 |
Hypertension | 26 (33.3%) | 12 (41.1%) | 0.440 |
Coronary heart disease | 4 (5.1%) | 5 (17.2%) | 0.106 |
History of smoking, n (%) | 32 (41.0%) | 11 (37.9%) | 0.772 |
History of alcohol consumption, n (%) | 28 (35.9%) | 11 (37.9%) | 0.846 |
Previous abdominal surgery, n (%) | 18 (23.1%) | 7 (24.1) | 0.908 |
Hepatitis B virus infection, n (%) | 13 (16.7%) | 4 (13.8%) | 0.949 |
Cholesterol, U/ml | 4.9±1.6 | 4.4±0.83 | 0.155 |
PT | 11.8±1.2 | 11.8±1.0 | 0.912 |
CA-19-9, U/ml | 95.8 (18.5,527.3) | 192.4 (22.1,904.3) | 0.471 |
AFP, U/ml | 3.2 (2.1,5.8) | 3.6 (2.7,5.3) | 0.651 |
CEA, U/ml | 3.8 (1.8,23.6) | 4.7 (2.8,17.0) | 0.373 |
Mononuclear count, 109/ml | 0.8±1.5 | 0.5±0.16 | 0.297 |
Neutrophil count, 109/ml | 4.6±2.2 | 4.3±1.6 | 0.461 |
Lymphocyte count, 109/ml | 4.5±22.6 | 6.6±22.6 | 0.688 |
Platelet count, 109/ml | 231.4±81.1 | 232.2±73.7 | 0.961 |
HGB, g/L | 131.9±18.7 | 136.8±18.5 | 0.237 |
ALT, U/L | 19.5 (13.0,33.3) | 18.0 (12.5,28.0) | 0.360 |
AST, U/L | 24.0 (18.0,36.5) | 22.0 (18.0,27.5) | 0.408 |
TBIL, umol/L | 12.9 (8.5,21.0) | 12.3 (10.1,14.6) | 0.408 |
ALB, g/L | 41.0±5.0 | 43.2±4.0 | 0.039 |
Preoperative antitumor treatment, n (%) | 4 (5.1%) | 2 (6.9%) | 0.661 |